Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 04. November 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9136  Previews Next
   
   Articles 1 - 20 / 182705  
   
Evaluation of large language models for clinical decision support in prostate cancer: a multidisciplinary Delphi study.
J Comp Eff Res
Borque-Fernando Á, Ledo Cepero MJ, Rodríguez-Fernández A, Espinós EL, Breijo SM, Gordoa TA, Campos FL, Bosch ME, Fernández EG, Rivas JG, Vilanova Busquets JC, Perez-Fentes D.
PMID: 42980497 [PubMed - as supplied by publisher]


Evaluation of large language models for guideline-based clinical questions in muscle-invasive and non-muscle-invasive bladder cancer and upper tract urothelial carcinoma: a multidisciplinary Delphi study.
J Comp Eff Res
Guerrero-Ramos F, Fernández Gómez JM, Aparicio TF, López-Beltrán A, Rueda ÓB, González LL, Vázquez JP, Carrión A, Iriarte AL, Subiela Henríquez JD, Couñago F, Benavides JM, Gómez PP, Juan Fita MJ, Vilaseca RM, Vilaseca A, Sureda LL, de Lorca AP, Domínguez Escrig JL, Ortega JS, Fernández ES, Plata Bello AC, Auba FV, Villa MT, Vargas EV, Puigsureda IT, Borque-Fernando Á.
PMID: 42980491 [PubMed - as supplied by publisher]


Evaluation of large language models for clinical decision support in renal cell carcinoma: a multidisciplinary Delphi study.
J Comp Eff Res
Montes SF, García IO, Martín RB, Agustín Ferrández MJ, Arrea FA, Esteban EC, Imbroda BH, Mir Maresma MC, Nicolau C, Perdigó MS, Velasco Oria de Rueda G, Borque-Fernando Á.
PMID: 42980485 [PubMed - as supplied by publisher]


Incretin-Based Therapies in Prostate Cancer: From Metabolic Protection to Potential Antitumour Activity - A Narrative Review.
Endocr Relat Cancer
Talmor B, Crumbaker M, Greenfield J, Joshua A.
PMID: 42980483 [PubMed - as supplied by publisher]


Evaluation of large language models for clinical decision support in penile and testicular cancer: a multidisciplinary Delphi study.
J Comp Eff Res
Rubio-Briones J, Reyes LI, Rodríguez JG, Herranz UA, Sánchez AR, Cabo González JA, Sánchez AS, Esteban MD, de Liaño Lista AG, Gutiérrez PG, Barona RL, Cardesa OG, Gómez-Aparicio MA, Muñoz Iglesias JL, Rodríguez-Fraile M, Martínez AO, Gaya JM, Rodríguez-Bermejo PR, Borque-Fernando Á.
PMID: 42980481 [PubMed - as supplied by publisher]


Feedforward Control Combined With Refined Management: Perioperative Nursing Outcomes for Robot‑Assisted Radical Prostatectomy.
Br J Hosp Med (Lond)
Xu J, Zheng Q, Guan R, Wu H.
PMID: 42980109 [PubMed - indexed for MEDLINE]


Comparison of first-line treatment strategies for metastatic hormone-sensitive prostate cancer in Japanese clinical practice since 2020: a multicenter registry study.
Jpn J Clin Oncol
Ueda T, Hayakawa K, Ota Y, Murashita J, Takahashi H, Saito Y, Miyashita M, Shiraishi T, Fujihara A, Okumi M, Asakawa Y, Harada Y, Yamada T, Ukimura O, Kyoto Prefectural University of Medicine Prostate Cancer Study Group.
PMID: 42979819 [PubMed - as supplied by publisher]


Reply to Xin Li and Yapeng Xing's Letter to the Editor re: Nielsen N.K, Hjort P.B, Hansen E.B, et al. Substaging and stratified treatment of T1 bladder cancer - a nationwide register-based study. Eur Urol Open Sci 2026;90:92-100.
Eur Urol Open Sci
Nielsen NK, Jensen JB.
PMID: 42979549 [PubMed]


From epidemiology to molecular pathology: current research status and future prospects on the role of toxic metal exposure in the development and progression of bladder cancer.
Front Cell Dev Biol
Li D, Sun X, Yu T.
PMID: 42978876 [PubMed]


Editorial: Kidney cancer awareness month 2025: current progress and future prospects on kidney cancer prevention, diagnosis and treatment.
Front Oncol
Mottaran A, Sfakianos JP, Flaifel A, Margulis V.
PMID: 42978713 [PubMed]


Multilevel Strategies to Reduce Prostate Cancer Disparities among Black Men in Underserved Communities in Memphis, TN: A Scoping Review.
Public Health Nurs
Reed F, Augusta T, Mary A.
PMID: 42978285 [PubMed - as supplied by publisher]


Evolution of treatment distribution and patient characteristics of muscle invasive bladder cancer patients: results from two multi-national real-world surveys.
BMC Urol
Y Patel M, Wang X, Castelino R, Milloy N, Unsworth M, Manuel L, Biondi E, Brown E, Skilling J.
PMID: 42977952 [PubMed - indexed for MEDLINE]


DV-Based Kidney-Sparing Therapy for High-Risk Upper Tract Urothelial Carcinoma: An Exploratory Single-Center Real-World Study.
Clin Genitourin Cancer
Wang A, Wang D, Zhang X, Shi J, Chen M, Ren S.
PMID: 42977653 [PubMed - as supplied by publisher]


A Call for a Prospective Multicenter Trial of Percutaneous Ablation for Renal Cell Carcinoma.
J Vasc Interv Radiol
Reis SP, Quencer K, Short R, McClure T, Gunn AJ.
PMID: 42977119 [PubMed - as supplied by publisher]


Niosomal encapsulation enhances thymoquinone-induced apoptosis in androgen-independent prostate cancer: an integrated DFT, docking, ADMET and cellular study.
Eur J Pharm Biopharm
Gedik G, Dulger G, Kiliccioglu I, Musatat AB, Akkoyunlu A, Karagoz U.
PMID: 42977097 [PubMed - as supplied by publisher]


KAMP-Net: Knowledge-aligned Multi-modal Prompt-tuning Network for Prostate Cancer Diagnosis from bpMRI.
Med Image Anal
Yuan Y, Bao J, Ge X, Ji L, Chen C, Shen H, Zhao L, Heng PA.
PMID: 42976526 [PubMed - as supplied by publisher]


Neoadjuvant Apalutamide With or Without Abiraterone Acetate Plus Prednisone and Gonadotropin-Releasing Hormone Agonist Prior to Nerve-Sparing Radical Prostatectomy in High-Risk Prostate Cancer: Protocol for a Randomized Phase 2 Trial.
JMIR Res Protoc
Zhang AY, Stein MN, Ghodoussipour S, Kim IY.
PMID: 42976301 [PubMed - indexed for MEDLINE]


Prediction of residual disease after chemotherapy in advanced NSGCT - does microRNA provide clinical benefits?
Klin Onkol
Pokriv, Hrstka R, , Lakomý R, Poprach A, Staník M, Babánková I, K, Kiss I.
PMID: 42975996 [PubMed - indexed for MEDLINE]


Can a negative PSMA PET/CT limit the indication for lymphadenectomy in patients with localized moderate- and high-risk prostate cancer?
Klin Onkol
Dianová K, , Paldus V.
PMID: 42975993 [PubMed - indexed for MEDLINE]


A European multicenter cohort study of patients with oligometastatic prostate cancer receiving stereotactic body radiotherapy for non-spinal bone metastases.
Strahlenther Onkol
Nägler F, Schäfer S, Seiler I, von Wachter C, Balermpas P, Loi M, Simontacchi G, Slavik M, Burkon P, Meents J, Giordano FA, Lohaus F, Willner J, Schunn AS, Drabke S, Klischies K, Wittenstein O, Bank P, Partl R, Müller JA, Gawish A, Grün A, Baehr A, Trommer M, Gkika E, Mader T, Holy R, Dzierma Y, Ehret F, Rühle A, Guckenberger M, Moustakis C, Brunner T, Blanck O, Nicolay NH, Boda-Heggemann J, Kästner L.
PMID: 42975650 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 182705    Page 1 of 9136  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1